Sandboxes As A Potential Source Of Dangerous Drug-Resistant Escherichia Coli And Staphylococcus Aureus Strains

1. Adler A., Katz D. E., Marchaim D.: The continuing plague of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections. Infect. Dis. Clin. North Am. 30, 347–375 (2016) Adler A. Katz D. E. Marchaim D. The continuing plague of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections. Infect. Dis. Clin. North Am 30 347 375 201610.1016/j.idc.2016.02.00327208763 Search in Google Scholar

2. Ambler R.: The structure of beta-lactamases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 289, 321–331 (1980) Ambler R. The structure of beta-lactamases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 289 321 331 198010.1098/rstb.1980.00496109327 Search in Google Scholar

3. Andriole V.: Quinolones: Past, Present and Future. Clin. Infect. Dis. 41, 113–115 (2005) Andriole V. Quinolones: Past, Present and Future. Clin. Infect. Dis 41 113 115 200510.1086/42805115942877 Search in Google Scholar

4. Badura A., Luxner J., Feierl G., Reinthaler F., Zarfel G., Galler H., Pregartner G., Riedl R., Grisold A.: Prevalence, antibiotic resistance patterns and molecular characterization of Escherichia coli from Austrian sandpits. Environm. Pol. 194, 24–30 (2014) Badura A. Luxner J. Feierl G. Reinthaler F. Zarfel G. Galler H. Pregartner G. Riedl R. Grisold A. Prevalence, antibiotic resistance patterns and molecular characterization of Escherichia coli from Austrian sandpits. Environm. Pol. 194 24 30 201410.1016/j.envpol.2014.07.00725089889 Search in Google Scholar

5. Baldy-Chudzik K., Bok E., Mazurek J.: Znane i nowe warianty patogennych Escherichia coli jako konsekwencja plastycznego genomu. Postępy Hig. Med. Dosw. 69, 345–361 (2015) Baldy-Chudzik K. Bok E. Mazurek J. Znane i nowe warianty patogennych Escherichia coli jako konsekwencja plastycznego genomu. Postępy Hig. Med. Dosw 69 345 361 201510.5604/17322693.114517325811471 Search in Google Scholar

6. Bebrone C.: Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74, 1686–1701 (2007) Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol 74 1686 1701 200710.1016/j.bcp.2007.05.02117597585 Search in Google Scholar

7. Bondi J.A., Diez C.C.: Penicillin resistant Staphylococci. Proc. Royal. Soc. Exper. Biol. Med. 60, 55–58 (1945) Bondi J.A. Diez C.C. Penicillin resistant Staphylococci Proc. Royal. Soc. Exper. Biol. Med 60 55 58 194510.3181/00379727-60-1508921004029 Search in Google Scholar

8. Brown D.F., Edwards D.I., Hawkey P.M., Morrison D., Ridgway G.L., Towner K.J., Wren M.W.: Joint Working Party of the British Society for Antimicrobial Chemotherapy; Hospital Infection Society; Infection Control Nurses Association. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J. Antimicrob. Chemother. 56, 1000–1018 (2005) Brown D.F. Edwards D.I. Hawkey P.M. Morrison D. Ridgway G.L. Towner K.J. Wren M.W. Joint Working Party of the British Society for Antimicrobial Chemotherapy; Hospital Infection Society; Infection Control Nurses Association. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J. Antimicrob. Chemother. 56 1000 1018 200510.1093/jac/dki37216293678 Search in Google Scholar

9. Burkhardt W., Calci K., Watkins W., Rippey S.R., Chirtel S.J.: Inactivation of indicator microorganisms in estuarine waters. Water Res. 34, 2207–2214 (2000) Burkhardt W. Calci K. Watkins W. Rippey S.R. Chirtel S.J. Inactivation of indicator microorganisms in estuarine waters. Water Res. 34 2207 2214 200010.1016/S0043-1354(99)00399-1 Search in Google Scholar

10. Bush K., Bradford P.A.: β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harb. Perspect. Med. DOI: 10.1101/cshperspect.a025247 (2016) Bush K. Bradford P.A. β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harb. Perspect. Med. DOI: 10.1101/cshperspect.a025247 2016496816427329032 Open DOISearch in Google Scholar

11. Bush K., Jacoby G.A.: Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 54, 969–976 (2010) Bush K. Jacoby G.A. Updated functional classification of β-lactamases. Antimicrob Agents Chemother 54 969 976 201010.1128/AAC.01009-09282599319995920 Search in Google Scholar

12. Bush K., Zgurskaya H.I. i wsp.: Tackling antibiotic resistance. Nat. Rev. Microbiol. 9, 894–896 (2011) Bush K. Zgurskaya H.I. Tackling antibiotic resistance. Nat. Rev. Microbiol 9 894 896 201110.1038/nrmicro2693420694522048738 Search in Google Scholar

13. Bush K.: Proliferation and significance of clinically relevant β-lactamases. Ann. N.Y. Acad. Sci. 1277, 84–90 (2013) Bush K. Proliferation and significance of clinically relevant β-lactamases. Ann. N.Y. Acad. Sci 1277 84 90 201310.1111/nyas.1202323346859 Search in Google Scholar

14. Campbell E.A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., Darst S.A.: Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 104, 901–912 (2001) Campbell E.A. Korzheva N. Mustaev A. Murakami K. Nair S. Goldfarb A. Darst S.A. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104 901 912 200110.1016/S0092-8674(01)00286-011290327 Search in Google Scholar

15. Chambers H.F.: The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7, 178–182 (2001) Chambers H.F. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis 7 178 182 200110.3201/eid0702.010204263171111294701 Search in Google Scholar

16. Chen Ch-M., Huang M., Chen H-F., Ke S-Ch., Li Ch-R, Wang J-H., Wu L-W.: Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC Microbiol. DOI: 10.1186/1471-2180-11-98 (2011) Chen Ch-M. Huang M. Chen H-F. Ke S-Ch. Li Ch-R Wang J-H. Wu L-W. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC Microbiol. DOI: 10.1186/1471-2180-11-98 2011311470421569422 Open DOISearch in Google Scholar

17. Cornaglia G., Giamarellou H., Rossolini G.M.: Metallo-βlactamases: a last frontier for β-lactams. Lancet, Infect. Dis. 11, 381–393 (2011) Cornaglia G. Giamarellou H. Rossolini G.M. Metallo-βlactamases: a last frontier for β-lactams. Lancet, Infect. Dis 11 381 393 201110.1016/S1473-3099(11)70056-121530894 Search in Google Scholar

18. Culp E.J., Waglechner N., Wang W., Fiebig-Comyn A.A., Hsu Y.-P., Koteva K., Sychantha D., Coombes B.K., Van Nieuwenhze M.S., Brun Y.V., Wang W. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature, 578, 582–587 (2020). Culp E.J. Waglechner N. Wang W. Fiebig-Comyn A.A. Hsu Y.-P. Koteva K. Sychantha D. Coombes B.K. Van Nieuwenhze M.S. Brun Y.V. Wang W. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature 578 582 587 202010.1038/s41586-020-1990-932051588 Search in Google Scholar

19. da Costa P.M., Loureiro L., Matos A.J.: Transfer of multidrug-resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment. Int. J. Environ. Res. Public Health. 10, 278–294 (2013) da Costa P.M. Loureiro L. Matos A.J. Transfer of multidrug-resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment. Int. J. Environ. Res. Public Health 10 278 294 201310.3390/ijerph10010278356414223343983 Search in Google Scholar

20. Depardieu F., Podglajen I., Leclercq R., Collaz E., Courvalin P.: Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20, 79–114 (2007) Depardieu F. Podglajen I. Leclercq R. Collaz E. Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20 79 114 200710.1128/CMR.00015-06179762917223624 Search in Google Scholar

21. Eady E., Cove J. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections, Curr. Opin. Infect. Dis. 16, 103–24 (2003) Eady E. Cove J. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections Curr. Opin. Infect. Dis 16 103 24 200310.1097/00132980-200302030-00004 Search in Google Scholar

22. El-Hajj Z.W., Newman E.B.: An Escherichia coli mutant that makes exceptionally long cells. J. Bacteriol. 197, 1507–1514 (2015) El-Hajj Z.W. Newman E.B. An Escherichia coli mutant that makes exceptionally long cells. J. Bacteriol 197 1507 1514 201510.1128/JB.00046-15437273525691528 Search in Google Scholar

23. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., Sprat B.G.: The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA, 99, 7687–7692 (2002) Enright M.C. Robinson D.A. Randle G. Feil E.J. Grundmann H. Sprat B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99 7687 7692 200210.1073/pnas.12210859912432212032344 Search in Google Scholar

24. Erickson M.C., Habteselassie M.Y., Liao J., Webb C.C., Mantripragada V., Davey L., Doyle M.P.: Examination off actors for use as potential predictors of human enteric pathogen survival in soil. J. Appl. Microbiol. 116, 335–349 (2014) Erickson M.C. Habteselassie M.Y. Liao J. Webb C.C. Mantripragada V. Davey L. Doyle M.P. Examination off actors for use as potential predictors of human enteric pathogen survival in soil. J. Appl. Microbiol 116 335 349 201410.1111/jam.1237324224858 Search in Google Scholar

25. Escherich T.: Die Darmbakterien des Neugeboren und Säuglings. Fortschr. Med. 3, 515–522, 547–557 (1885) Escherich T. Die Darmbakterien des Neugeboren und Säuglings. Fortschr. Med 3 515 522 547 557 1885 Search in Google Scholar

26. Fuda C., Suvorov M., Vakulenko S.B., Mobashery S.: The basis for resistance to β-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J. Biol. Chem. 279, 40802–40806 (2004) Fuda C. Suvorov M. Vakulenko S.B. Mobashery S. The basis for resistance to β-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus J. Biol. Chem. 279 40802 40806 200410.1074/jbc.M40358920015226303 Search in Google Scholar

27. Gardete S., Tomasz A.: Mechanisms of vancomycin resistance in Staphylococcus aureus. J. Clin. Invest. 124, 2836–2840 (2014) Gardete S. Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus J. Clin. Invest. 124 2836 2840 201410.1172/JCI68834407140424983424 Search in Google Scholar

29. Gaurav K., Karmakar S., Kundu K., Kundu S.: Design, development and synthesis of novel cephalosporin group of antibiotics [W]: Antibiotic resistant bacteria – a continuous challenge in the new millennium. red. M. Pana, IntechOpen, 2012, s. 487–502 Gaurav K. Karmakar S. Kundu K. Kundu S. Design, development and synthesis of novel cephalosporin group of antibiotics [W]: Antibiotic resistant bacteria – a continuous challenge in the new millennium red. Pana M. IntechOpen 2012 s. 487 502 10.5772/29658 Search in Google Scholar

29. Girard M., Steele D., Chaignat C.-L., Kieny M.P.: A review of vaccine research and development: human enteric infections. Vaccine, 24, 2732–2750 (2006) Girard M. Steele D. Chaignat C.-L. Kieny M.P. A review of vaccine research and development: human enteric infections. Vaccine 24 2732 2750 200610.1016/j.vaccine.2005.10.01416483695 Search in Google Scholar

30. Gnanamani A., Hariharan P., Satyaseela M.: Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach [W:] Frontiers in Staphylococcus aureus. IntechOpen, 2017, s. 3–16 Gnanamani A. Hariharan P. Satyaseela M. Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach [W:] Frontiers in Staphylococcus aureus. IntechOpen 2017 s. 3 16 10.5772/67338 Search in Google Scholar

31. Gotkowska-Pachta A., Korzeniowska E.: Microbial evaluation of sandboxes located in urban areas. Ecotox. and Environ. 113, 64–71 (2015) Gotkowska-Pachta A. Korzeniowska E. Microbial evaluation of sandboxes located in urban areas. Ecotox. and Environ 113 64 71 201510.1016/j.ecoenv.2014.11.02925483374 Search in Google Scholar

32. Greenwood D., O’Grady F.: Scanning electron microscopy of Staphylococcus aureus exposed to some common anti-staphylococcal agents. J. Gen. Microbiol. 70, 263–270 (1972) Greenwood D. O’Grady F. Scanning electron microscopy of Staphylococcus aureus exposed to some common anti-staphylococcal agents. J. Gen. Microbiol 70 263 270 197210.1099/00221287-70-2-2634483215 Search in Google Scholar

33. Hartman A., Tomasz B: History of antibiotics and suphonamides discoveries. Pol. Merkur. Lek. 30, 320–322 (2011) Hartman A. Tomasz B History of antibiotics and suphonamides discoveries. Pol. Merkur. Lek. 30 320 322 2011 Search in Google Scholar

34. Jasiewicz J., Baran A., Antoniewicz J.: Assessment of chemical composition and sanitary state of sand in selected sandboxes in Krakow. J. Elementol. 14, 79–90 (2009) Jasiewicz J. Baran A. Antoniewicz J. Assessment of chemical composition and sanitary state of sand in selected sandboxes in Krakow. J. Elementol. 14 79 90 200910.5601/jelem.2009.14.1.09 Search in Google Scholar

35. Jevons M.: Celbenin-resistant staphylococci. Br. Med. J. 1, 124–125 (1961) Jevons M. Celbenin-resistant staphylococci. Br. Med. J 1 124 125 196110.1136/bmj.1.5219.124-a Search in Google Scholar

36. Kim K.S.: Human meningitis-associated Escherichia coli. EcoSal Plus. DOI: 10.1128/ecosalplus.ESP-0015-2015 (2016) Kim K.S. Human meningitis-associated Escherichia coli EcoSal Plus DOI: 10.1128/ecosalplus.ESP-0015-2015 2016488143027223820 Open DOISearch in Google Scholar

37. Kim Y., Qureshi Z., Adams-Haduch J.: Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin. Infect. Dis. 55, 224–231 (2012) Kim Y. Qureshi Z. Adams-Haduch J. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin. Infect. Dis. 55 224 231 201210.1093/cid/cis387349177322491340 Search in Google Scholar

38. Kirby W.M.: Extraction of highly potent penicillin inactivator from penicillin resistant Staphylocooci. Science 99, 452–453 (1942) Kirby W.M. Extraction of highly potent penicillin inactivator from penicillin resistant Staphylocooci Science 99 452 453 194210.1126/science.99.2579.45217798398 Search in Google Scholar

39. Kirk M., Pires S., Black R., Caipo M., Crump J., Devleesschauwer B.: World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases. PLoS Med. DOI: 10.1371/journal.pmed.1001921 (2015) Kirk M. Pires S. Black R. Caipo M. Crump J. Devleesschauwer B. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases. PLoS Med DOI: 10.1371/journal.pmed.1001921 2015466883126633831 Open DOISearch in Google Scholar

40. Köhler C, Dobrindt U.: What deines extraintestinal pathogenic Escherichia coli? Int. J. Med. Microbiol. 301, 642–647 (2011) Köhler C Dobrindt U. What deines extraintestinal pathogenic Escherichia coli? Int. J. Med. Microbiol. 301 642 647 201110.1016/j.ijmm.2011.09.00621982038 Search in Google Scholar

41. Korzybski D., Nowiński A.: Makrolidy – nie tylko działanie przeciwbakteryjne. Forum Med. Rodz. 7, 271–276 (2013) Korzybski D. Nowiński A. Makrolidy – nie tylko działanie przeciwbakteryjne. Forum Med. Rodz. 7 271 276 2013 Search in Google Scholar

42. Kozińska A., Sitkiewicz I.: Nowe i stare antybiotyki – mechanizmy działania i strategie poszukiwania leków przeciwbakteryjnych. Kos. Prob. N. Biol. 314, 109–124 (2017) Kozińska A. Sitkiewicz I. Nowe i stare antybiotyki – mechanizmy działania i strategie poszukiwania leków przeciwbakteryjnych. Kos. Prob. N. Biol 314 109 124 2017 Search in Google Scholar

43. Lee S.Y., Kotapati S., Kuti J.L., Nightingale C.H., Nicolau D.P.: Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol. 27, 1226–1232 (2006) Lee S.Y. Kotapati S. Kuti J.L. Nightingale C.H. Nicolau D.P. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27 1226 1232 200610.1086/50796217080381 Search in Google Scholar

44. Licitra G.: Etymologia: Staphylococcus. Emerg Infect Dis. 19, 1553 (2013) Licitra G. Etymologia: Staphylococcus Emerg Infect Dis 19 1553 201310.3201/eid1909.ET1909 Search in Google Scholar

45. Ling L., Lewis K. i wsp.: A new antibiotic kills pathogens without detectable resistance. Nature, 517, 455–459 (2015) Ling L. Lewis K. A new antibiotic kills pathogens without detectable resistance. Nature 517 455 459 201510.1038/nature14098741479725561178 Search in Google Scholar

46. Liu G.Y., Essex A., Buchanan J.T., Data V., Hofman H.M., Bastian J.F., Fierer J., Nizet V..: Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med. 202, 209–215 (2005) Liu G.Y. Essex A. Buchanan J.T. Data V. Hofman H.M. Bastian J.F. Fierer J. Nizet V. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202 209 215 200510.1084/jem.20050846221300916009720 Search in Google Scholar

47. Liu Y., Wang Y., Walsh T. R., Yi L. X., Zhang R., Spencer J., Doi Y., Tian G., Ding B., Huang X.: Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet. Infect. Dis. 16, 161–168 (2016) Liu Y. Wang Y. Walsh T. R. Yi L. X. Zhang R. Spencer J. Doi Y. Tian G. Ding B. Huang X. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet. Infect. Dis 16 161 168 201610.1016/S1473-3099(15)00424-726603172 Search in Google Scholar

48. Lofmark S., Edlund C., Nord C. E.: Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin. Infect. Dis. 50, 16–23 (2010) Lofmark S. Edlund C. Nord C. E. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin. Infect. Dis 50 16 23 201010.1086/64793920067388 Search in Google Scholar

49. Lowy F.D.: Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111, 1265–1273 (2003) Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus J. Clin. Invest 111 1265 1273 200310.1172/JCI1853515445512727914 Search in Google Scholar

50. Lu Y., Sasakia T., Kuwahara-Arai K., Ueharaa Y., Hiramatsua K.: Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities. Appl. Environ. Microbiol. 84, 517–518 (2018) Lu Y. Sasakia T. Kuwahara-Arai K. Ueharaa Y. Hiramatsua K. Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities. Appl. Environ. Microbiol. 84 517 518 201810.1128/AEM.00517-18596095729625975 Search in Google Scholar

51. Markiewicz Z, Kwiatkowski Z.: Bakterie, antybiotyki, lekooporność. PWN, Warszawa; 2019 Markiewicz Z Kwiatkowski Z. Bakterie, antybiotyki, lekooporność. PWN Warszawa 2019 Search in Google Scholar

52. Maslikowska J.A., Walker S.A., Elligsen M., Mitman N., Palmay L., Daneman N., Simor A.: Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J. Hosp. Infect. 92, 33–41 (2016) Maslikowska J.A. Walker S.A. Elligsen M. Mitman N. Palmay L. Daneman N. Simor A. Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J. Hosp. Infect 92 33 41 201610.1016/j.jhin.2015.10.00126597637 Search in Google Scholar

53. Mazur E. Występowanie lekoopornych szczepów Staphylococcus aureus i Escherichia coli w miejscach użyteczności publicznej jako potencjalny czynnik zagrożenia zdrowia. Praca magisterska. Uniwersytet Rolniczy w Krakowie (2018) Mazur E. Występowanie lekoopornych szczepów Staphylococcus aureus i Escherichia coli w miejscach użyteczności publicznej jako potencjalny czynnik zagrożenia zdrowia. Praca magisterska. Uniwersytet Rolniczy w Krakowie 2018 Search in Google Scholar

54. Matzov D., Yonath A. i wsp.: Structural insights of lincosamides targeting the ribosome of Staphylococcus aureus, Nucleic Acids. Research. 45, 10284–10286 (2017) Matzov D. Yonath A. Structural insights of lincosamides targeting the ribosome of Staphylococcus aureus Nucleic Acids. Research. 45 10284 10286 201710.1093/nar/gkx658562232328973455 Search in Google Scholar

55. Mendelson M., Balasegaram M., Jinks T., Pulcini C., Sharland M.: Antibiotic resistance has a language problem. Macmillan Publishers Limited, part of Springer Nature https://www. nature.com/news/antibiotic-resistance-has-a-language-problem-1.21915 (20.05.2020) Mendelson M. Balasegaram M. Jinks T. Pulcini C. Sharland M. Antibiotic resistance has a language problem. Macmillan Publishers Limited, part of Springer Nature https://www. nature.com/news/antibiotic-resistance-has-a-language-problem-1.21915 (20.05.2020) 10.1038/545023a28470219 Search in Google Scholar

56. Miller L., Diep B.: Colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection, Clin. Infect. Dis. 46, 452–460 (2008) Miller L. Diep B. Colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection Clin. Infect. Dis 46 452 460 200810.1086/52677318220477 Search in Google Scholar

57. Muñiz C.C., Zelaya T.E., Esquivel G.R., Fernández F.J.: Penicillin and cephalosporin production: a historical perspective. Rev Latinoam Microbiol. 49, 88–98 (2007) Muñiz C.C. Zelaya T.E. Esquivel G.R. Fernández F.J. Penicillin and cephalosporin production: a historical perspective. Rev Latinoam Microbiol. 49 88 98 2007 Search in Google Scholar

58. Neidhardt F, Ingraham J., Schaechter M.: Physiology of the Bacterial Cell: A molecular approach, Sinauer Associates, Chicago 1990 Neidhardt F Ingraham J. Schaechter M. Physiology of the Bacterial Cell: A molecular approach Sinauer Associates Chicago 1990 Search in Google Scholar

59. Nwachuku N., Gerba Ch.: Microbial risk assessment: don‘t forget the children. Curr. Opin. Microbiol. 7, 206–209 (2004) Nwachuku N. Gerba Ch. Microbial risk assessment: don‘t forget the children. Curr. Opin. Microbiol. 7 206 209 200410.1016/j.mib.2004.04.01115196486 Search in Google Scholar

60. O’Neill J.: The Review on Antimicrobial Resistance Tackling Drug-resistant Infections Globally: Final Report and Recommendations (HM Government/Wellcome Trust, 2016); Protokół dostępu http://go.nature. com/2oj9uan (20.05.2020) O’Neill J. The Review on Antimicrobial Resistance Tackling Drug-resistant Infections Globally: Final Report and Recommendations (HM Government/Wellcome Trust, 2016); Protokół dostępu http://go.nature. com/2oj9uan (20.05.2020) Search in Google Scholar

61. Ochman H., Wilson A.C.: Evolution in bacteria: Evidence for a universal substitution rate in cellular genomes. J. Molec. Evol. 26, 74–86 (1987) Ochman H. Wilson A.C. Evolution in bacteria: Evidence for a universal substitution rate in cellular genomes. J. Molec. Evol 26 74 86 198710.1007/BF021112833125340 Search in Google Scholar

62. Ochocki Z., Stańczak A.: Antybiotyki aminoglikozydowe. Farm. Pol. 61, 707–718 (2005) Ochocki Z. Stańczak A. Antybiotyki aminoglikozydowe. Farm. Pol. 61 707 718 2005 Search in Google Scholar

63. Oshiro R., Fujioka R.: Sand, soil and pigeon droppings: sources of indicator bacteria in the waters of Hanaumabay Oahu, Hawaii. Water Sci. Technol. 31, 251–254 (1995) Oshiro R. Fujioka R. Sand, soil and pigeon droppings: sources of indicator bacteria in the waters of Hanaumabay Oahu, Hawaii. Water Sci. Technol 31 251 254 199510.2166/wst.1995.0617 Search in Google Scholar

64. Overgaauw P.A.M., van Knapen F.: Veterinary and public health aspects of Toxocara spp. Vet. Parasitol. 193, 398–403 (2013) Overgaauw P.A.M. van Knapen F. Veterinary and public health aspects of Toxocara spp. Vet. Parasitol. 193 398 403 201310.1016/j.vetpar.2012.12.03523305972 Search in Google Scholar

65. Pantel L., Gualtieri M. i wsp.: Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site. Mol Cell. 70, 83–94 (2018) Pantel L. Gualtieri M. Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site. Mol Cell 70 83 94 201810.1016/j.molcel.2018.03.00129625040 Search in Google Scholar

66. Pappelbaum K., Kasprzak J., Czaczyk K.: Występowanie werotoksycznych Escherichia coli w żywności, ze szczególnym uwzględnieniem serotypu O104:H4. Żywność. Nauka. Technologia. Jakość. 5, 33–48 (2015) Pappelbaum K. Kasprzak J. Czaczyk K. Występowanie werotoksycznych Escherichia coli w żywności, ze szczególnym uwzględnieniem serotypu O104:H4. Żywność. Nauka. Technologia. Jakość. 5 33 48 2015 Search in Google Scholar

67. Patel G., Bonomo R.A.: Stormy waters ahead: global emergence of carbapenemases. Front Microbiol. DOI: 10.3389/fmicb.2013.00048 (2013) Patel G. Bonomo R.A. Stormy waters ahead: global emergence of carbapenemases. Front Microbiol. DOI: 10.3389/fmicb.2013.00048 2013359678523504089 Open DOISearch in Google Scholar

68. Perry J., Waglechner N, Wright G.: The prehistory of antibiotic resistance. Cold Spring Harb. Perspect. Med. 6, DOI:10.1101/cshperspect.a025197 (2016) Perry J. Waglechner N Wright G. The prehistory of antibiotic resistance. Cold Spring Harb. Perspect. Med. 6 DOI:10.1101/cshperspect.a025197 2016488881027252395 Open DOISearch in Google Scholar

69. PN-EN 1176-1:07.2009 Wyposażenie placów zabaw i nawierzchnie. Część 1: Ogólne wymagania bezpieczeństwa i metody badań PN-EN 1176-1:07.2009 Wyposażenie placów zabaw i nawierzchnie. Część 1: Ogólne wymagania bezpieczeństwa i metody badań Search in Google Scholar

70. Rammelkamp C.H., Maxon T.: Resistance of Staphylococcus aureus to the action of penicillin. Exp. Biol. Med. 51, 386–389 (1942) Rammelkamp C.H. Maxon T. Resistance of Staphylococcus aureus to the action of penicillin. Exp. Biol. Med 51 386 389 194210.3181/00379727-51-13986 Search in Google Scholar

71. Rasheed J.K., Kitchel B., Zhu W., Anderson K.F., Clark N.C., Ferraro M.J., Savard P., Humphries R.M., Kallen A.J., Limbago B.M.: New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States. Emerg. Infect. Dis. 19, 870–878 (2013) Rasheed J.K. Kitchel B. Zhu W. Anderson K.F. Clark N.C. Ferraro M.J. Savard P. Humphries R.M. Kallen A.J. Limbago B.M. New Delhi metallo-β-lactamase-producing Enterobacteriaceae United States. Emerg. Infect. Dis 19 870 878 201310.3201/eid1906.121515371382523731823 Search in Google Scholar

72. Reygaert W.C.: Antimicrobial resistance mechanisms of Staphylococcus aureus. [W]: Microbial pathogens and strategies for combating them: science, technology and education, red. A. Méndez-Vilas, Formatex Research Center, Hiszpania, 2013, s. 297–305 Reygaert W.C. Antimicrobial resistance mechanisms of Staphylococcus aureus [W]: Microbial pathogens and strategies for combating them: science, technology and education red. Méndez-Vilas A. Formatex Research Center Hiszpania 2013 s. 297 305 Search in Google Scholar

73. Schroeder E.K., De Souza N., Santos D.S., Blanchard J.S., Basso L.A.: Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr. Pharm. Biotechnol. 3, 197–225 (2002) Schroeder E.K. De Souza N. Santos D.S. Blanchard J.S. Basso L.A. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis Curr. Pharm. Biotechnol 3 197 225 200210.2174/138920102337832812164478 Search in Google Scholar

74. Schultsz C., Geerlings S.: Plasmid-mediated resistance in Enterobacteriaceae. Drugs. 72, 1–16 (2012) Schultsz C. Geerlings S. Plasmid-mediated resistance in Enterobacteriaceae Drugs 72 1 16 201210.2165/11597960-000000000-0000022191792 Search in Google Scholar

75. Shah A.H., Fleming L.E. i wsp.: Indicator microbes correlate with pathogenic bacteria, yeasts and helminths in sand at a subtropical recreational beach site. J. Appl. Microbiol. 110, 1571–1583 (2011) Shah A.H. Fleming L.E. Indicator microbes correlate with pathogenic bacteria, yeasts and helminths in sand at a subtropical recreational beach site. J. Appl. Microbiol 110 1571 1583 201110.1111/j.1365-2672.2011.05013.x21447014 Search in Google Scholar

76. Supuran C.: Special Issue: Sulfonamides, Molecules, 22, 1642 (2017) Supuran C. Special Issue: Sulfonamides Molecules 22 1642 201710.3390/molecules22101642615172228961201 Search in Google Scholar

77. Taylor S.D., Palmer M.: The action mechanism of daptomycin. Bioorg. Med. Chem. 24, 6253–6268 (2016) Taylor S.D. Palmer M. The action mechanism of daptomycin. Bioorg. Med. Chem 24 6253 6268 201610.1016/j.bmc.2016.05.05227288182 Search in Google Scholar

78. Thomson K.S.: Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J. Clin. Microbiol. 48, 1019–1025 (2010) Thomson K.S. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J. Clin. Microbiol. 48 1019 1025 201010.1128/JCM.00219-10284955620181902 Search in Google Scholar

79. Touhami A, Jericho MH, Beveridge TJ.: Atomic force microscopy of cell growth and division in Staphylococcus aureus. J. Bacteriol. 186, 3286–3295 (2004) Touhami A Jericho MH Beveridge TJ. Atomic force microscopy of cell growth and division in Staphylococcus aureus J. Bacteriol 186 3286 3295 200410.1128/JB.186.11.3286-3295.200441577815150213 Search in Google Scholar

80. Tupina A., Gualtieri M., Roquet-Bančresa F., Morichauda Z., Brodolina K., Leonettia J-P.: Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int. J. Antimicrob. Agents, 35, 519–523 (2010) Tupina A. Gualtieri M. Roquet-Bančresa F. Morichauda Z. Brodolina K. Leonettia J-P. Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int. J. Antimicrob. Agents 35 519 523 201010.1016/j.ijantimicag.2009.12.01720185278 Search in Google Scholar

81. UN News Centre.: UN announces interagency group to coordinate global fight against antimicrobial resistance, http://go.nature.com/2pcqx28 (20.05.2020) UN News Centre UN announces interagency group to coordinate global fight against antimicrobial resistance http://go.nature.com/2pcqx28 (20.05.2020) Search in Google Scholar

82. Van Bambeke F., Michot J.M., Van Eldere J., Tulkens P.M.: Quinolones in 2005: an update. Clin. Microbiol. Infect. 11, 256–280 (2005) Van Bambeke F. Michot J.M. Van Eldere J. Tulkens P.M. Quinolones in 2005: an update. Clin. Microbiol. Infect 11 256 280 200510.1111/j.1469-0691.2005.01131.x15760423 Search in Google Scholar

83. van de Sande-Bruinsma N., Grundmann H., Verloo D., Tiemersma E., Monen, J., Goossens H., Ferech M.: European antimicrobial resistance surveillance system group, European surveillance of antimicrobial consumption project group. Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis. 14, 1722–1730 (2008) van de Sande-Bruinsma N. Grundmann H. Verloo D. Tiemersma E. Monen J. Goossens H. Ferech M. European antimicrobial resistance surveillance system group, European surveillance of antimicrobial consumption project group. Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis 14 1722 1730 200810.3201/eid1411.070467263072018976555 Search in Google Scholar

84. Wellcome Trust: Exploring the Consumer Perspective on Antimicrobial Resistance (Wellcome Trust, 2015), http://go.nature.com/2pkwcbw (20.05.2020) Wellcome Trust Exploring the Consumer Perspective on Antimicrobial Resistance (Wellcome Trust, 2015) http://go.nature.com/2pkwcbw (20.05.2020) Search in Google Scholar

85. WHO: World Health Organization Antibiotic Resistance: Multi-Country Public Awareness Survey, http://go.nature.com/2ptdypm (20.05.2020) WHO World Health Organization Antibiotic Resistance: Multi-Country Public Awareness Survey http://go.nature.com/2ptdypm (20.05.2020) Search in Google Scholar

86. Wielders C., Fluit A.C., Brisse S., Verhoef J., Schmiz F.J.: mecA Gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol. 40, 3970–3975 (2002) Wielders C. Fluit A.C. Brisse S. Verhoef J. Schmiz F.J. mecA Gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol 40 3970 3975 200210.1128/JCM.40.11.3970-3975.200213964412409360 Search in Google Scholar

87. Yang Y.S., Ku C.H., Lin J.C., Shang ST., Chiu C.H., Yeh K.M., Lin C.C., Chang F.Y.: Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumonia on the outcome of community-onset bacteremic urinary tract infections. J. Microbiol. Immunol. Infect. 43, 194–199 (2010) Yang Y.S. Ku C.H. Lin J.C. Shang ST. Chiu C.H. Yeh K.M. Lin C.C. Chang F.Y. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumonia on the outcome of community-onset bacteremic urinary tract infections. J. Microbiol. Immunol. Infect 43 194 199 201010.1016/S1684-1182(10)60031-X21291846 Search in Google Scholar

88. Yigit H., Queenan A., Anderson G.: Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45, 1151–1161 (2001) Yigit H. Queenan A. Anderson G. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae Antimicrob. Agents Chemother 45 1151 1161 200110.1128/AAC.45.4.1151-1161.20019043811257029 Search in Google Scholar

89. Zalecenia Głównego Inspektora Sanitarnego z dnia 05.05.2009 r. GIS-BI-074-68-1/J0/09, http://www.pssedg.eu/ww_piaskownica.php (20.05.2020) Zalecenia Głównego Inspektora Sanitarnego z dnia 05.05.2009 r GIS-BI-074-68-1/J0/09, http://www.pssedg.eu/ww_piaskownica.php (20.05.2020) Search in Google Scholar

90. Zmysłowska I.: Mikrobiologia ogólna i środowiskowa. Teoria i ćwiczenia. Red. I. Zmysłowska, Wydawnictwo Uniwersytetu Warmińsko Mazurskiego, Olsztyn, 2009, s. 195 Zmysłowska I. Mikrobiologia ogólna i środowiskowa. Teoria i ćwiczenia. Red. Zmysłowska I. Wydawnictwo Uniwersytetu Warmińsko Mazurskiego Olsztyn 2009 s. 195 Search in Google Scholar